Citations

Mayo Clinic

Showing 10 of 108537 citations.

D158. Comparing Collagenase and Tissue Subcision for Cellulite Treatment of the Buttock and Thigh Regions: A Systematic Review and Meta-analysis
Raška, Otakar , Galinaud, Cécilia , Schuster, Kirsten A. , Ho, Olivia A. , TerKonda, Sarvam P. , Lin, Samuel J. , Foppiani, Jose , Stearns, Stephen, Alvarez, Angelica Hernandez , Taritsa, Iulianna C. , Lee, Bernard T.

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 142-142

10.1097/01.gox.0001019216.01877.e9 Get It

27. The Fate Of The Frozen Bone Flap: Quantitative Assessment Of Bone Flap Resorption Following Delayed Autologous Cranioplasty
Cherukuri, Sai , Zheng, Eugene, Emanuels, Andrew F., Bite, Uldis, Emanuels, Andrew, Gompel, Jamie J. Van , Morris, Jonathan M. , Mardini, Samir , Gibreel, Waleed

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 18-19

10.1097/01.gox.0001018124.22700.84 Get It

57. Larger Volume Silicone Breast Implants Are Safe In Breast Reconstruction: Data From The Athena Multicenter, Prospective Study Of 400 Patients
Garvey, Patrick B., Larsen, A. Denise, Skoracki, Roman J. , Djohan, Risal , Migliori, Mark R., Friedman, Jeffrey D., Serletti, Joseph M., Rebecca, Alanna M. , Kane, William J. , Tenenbaum, Marissa M.

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 33-34

10.1097/01.gox.0001018240.93275.53 Get It

QSAAPS02. Facial Skeleton Aging Pattern: AI-assisted Statistical Shape Modeling And Volumetric Analysis In The White Population
Hussein, Sara , Rames, Jess D. , Pazelli, Alexandre Meira, Abushehab, Abdallah, Wentworth, Adam, Sears, Victoria A. , Morris, Jonathan M. , Sharaf, Basel

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 1-1

10.1097/01.gox.0001017988.11406.83 Get It

TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy
Youssef, Hossam , Gatto, Rodolfo G. , Pham, Nha Trang Thu, Petersen, Ronald C. , Reichard, R. Ross , Jack, Clifford R. , Whitwell, Jennifer L., Josephs, Keith A. , Jack, Clifford R , Whitwell, Jennifer L , Youseff, Hossam , Machulda, Mary M. , Dickson, Dennis W. , Whitwell, Jennifer

Journal of Alzheimer’s Disease | May 10, 2024 | Volume: 99 | Issue: 3 | Pages: 1023-1032

10.3233/jad-240136 | PMID 38728190 Get It

Background: TAR DNA binding protein 43 (TDP-43) has been shown to be associated with whole hippocampal atrophy in primary age-related tauopathy (PART). It is currently unknown which subregions of the hippocampus are contributing to TDP-43 associated whole hippocampal atrophy in PART. Objective: To identify which specific hippocampal subfield regions are contributing to TDP-43-associated whole hippocampal atrophy in PART. Methods: A total of 115 autopsied cases from the Mayo Clinic Alzheimer Disease Research Center, Neurodegenerative Research Group, and the Mayo Clinic Study of Aging were analyzed. All cases underwent antemortem brain volumetric MRI, neuropathological assessment of the distribution of Aβ (Thal phase), and neurofibrillary tangle (Braak stage) to diagnose PART, as well as assessment of TDP-43 presence/absence in the amygdala, hippocampus and beyond. Hippocampal subfield segmentation was performed using FreeSurfer version 7.4.1. Statistical analyses using logistic regression were performed to assess for associations between TDP-43 and hippocampal subfield volumes, accounting for potential confounders. Results: TDP-43 positive patients ( n = 37, 32%), of which 15/15 were type-α, had significantly smaller whole hippocampal volumes, and smaller volumes of the body and tail of the hippocampus compared to TDP-43 negative patients. Subfield analyses revealed an association between TDP-43 and the molecular layer of hippocampal body and the body of cornu ammonis 1 (CA1), subiculum, and presubiculum regions. There was no association between TDP-43 stage and subfield volumes. Conclusions: Whole hippocampal volume loss linked to TDP-43 in PART is mainly due to volume loss occurring in the molecular layer, CA1, subiculum and presubiculum of the hippocampal body.
Management of the liver transplant candidate with high cardiac risk: Multidisciplinary best practices and recommendations
Pagano, Giulia , Chadha, Ryan , VanWagner, Lisa B. , Crespo, Gonzalo , Koshy, Anoop N , Chadha, Ryan , VanWagner, Lisa B , Crespo, Gonzalo

Liver Transplantation | May 10, 2024 | Volume: 30 | Issue: 12 | Pages: 1304-1315

10.1097/lvt.0000000000000396 | PMID 38727607 Get It

In a setting characterized by a growing prevalence of patients with alcohol-associated and metabolic dysfunction–associated steatotic liver diseases, coupled with an aging patient demographic, the incidence of cardiac comorbidities in liver transplant candidates is on the rise. These comorbidities not only pose barriers to transplant eligibility but also impact the intraoperative course and affect posttransplant outcomes. As such, there is a significant need to optimize the clinical management of these cardiac comorbidities. However, there is a scarcity of evidence regarding the best practices for managing cardiac comorbidities such as coronary and valvular heart diseases, arrhythmia, and cardiomyopathy in this population, both before and during transplant surgery. These conditions necessitate a coordinated and multidisciplinary approach to care. In this manuscript, we conduct a comprehensive review of the most recent evidence pertaining to the preoperative and intraoperative management of these cardiac comorbidities in liver transplant candidates. Our aim is to provide recommendations that improve and standardize their clinical care.
Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies
Mahipal, Amit , Storandt, Michael H. , Teslow, Emily A. , Jaeger, Ellen , Stoppler, Melissa C. , Jin, Zhaohui , Chakrabarti, Sakti , Mahipal, Amit , Jin, Zhaohui , Chakrabarti, Sakti , Jaeger, Ellen B , Teslow, Emily A

Cancers | May 10, 2024 | Volume: 16 | Issue: 10 | Pages: 1823

10.3390/cancers16101823 | PMID 38791902 Get It

Background: The predictive and prognostic role of BRAF alterations has been evaluated in colorectal cancer (CRC); however, BRAF alterations have not been fully characterized in non-CRC gastrointestinal (GI) malignancies. In the present study, we report the frequency and spectrum of BRAF alterations among patients with non-CRC GI malignancies. Methods: Patients with CRC and non-CRC GI malignancies who underwent somatic tumor profiling via a tissue-based or liquid-based assay were included in this study. Gain-of-function BRAF alterations were defined as pathogenic/likely pathogenic somatic short variants (SVs), copy number amplifications ≥8, or fusions (RNA or DNA). Results: Among 51,560 patients with somatic profiling, 40% had CRC and 60% had non-CRC GI malignancies. BRAF GOF alterations were seen more frequently in CRC (8.9%) compared to non-CRC GI malignancies (2.2%) (p < 0.001). Non-CRC GI malignancies with the highest prevalence of BRAF GOF alterations were bile duct cancers (4.1%) and small intestine cancers (4.0%). Among BRAF GOF alterations, class II (28% vs. 6.8%, p < 0.001) and class III (23% vs. 14%, p < 0.001) were more common in non-CRC GI malignancies. Among class II alterations, rates of BRAF amplifications (3.1% vs. 0.3%, p < 0.001) and BRAF fusions (12% vs. 2.2%, p < 0.001) were higher in non-CRC GI malignancies compared to CRC. Conclusions: Non-CRC GI malignancies demonstrate a distinct BRAF alteration profile compared to CRC, with a higher frequency of class II and III mutations, and more specifically, a higher incidence of BRAF fusions. Future studies should evaluate clinical implications for the management of non-CRC GI patients with BRAF alterations, especially BRAF fusions.
Systemic correlates of cutaneous manifestations of lupus erythematosus
Heil, Peter Maximilian , Pittelkow, Mark R. , Weaver, Amy L. , Killian, Jill M. , Sokumbi, Olayemi , Wetter, David A. , Heil, Peter M , Sokumbi, Olayemi

International Journal of Dermatology | May 10, 2024 | Volume: 63 | Issue: 8 | Pages: No page available

10.1111/ijd.17178 | PMID 38727096 Get It

Abstract Background We aimed to investigate the prevalence of skin disease among patients with systemic lupus erythematosus (SLE) and determine whether LE skin disease had clinical or serologic correlates with SLE. Methods We reviewed records of 335 patients with SLE (seen at Mayo Clinic, Rochester, Minnesota, USA) and abstracted skin manifestations, fulfilled mucocutaneous SLE criteria, and clinical and serologic parameters. Results Of the 231 patients with skin manifestations, 57 (24.7%) had LE‐specific conditions, 102 (44.2%) had LE‐nonspecific conditions, and 72 (31.2%) had both. LE skin disease was associated with photosensitivity, anti‐Smith antibodies, and anti‐U1RNP antibodies (all P < 0.001). Patients without LE skin disease more commonly had elevated C‐reactive protein levels ( P = 0.01). Patients meeting 2–4 mucocutaneous American College of Rheumatology criteria less commonly had cytopenia ( P = 0.004) or anti−double‐stranded DNA antibodies ( P = 0.004). No significant associations were observed for systemic involvement (renal, hematologic, neurologic, and arthritis) when comparing patients with or without LE skin involvement. LE skin involvement was not significantly associated with internal SLE disease flare, number of medications, or overall survival. Conclusions LE skin disease commonly occurs in patients with SLE. The presence of LE skin disease had no mitigating impact on the severity of SLE sequelae, disease flares, number of medications, or overall survival.
Outcomes of mechanical thrombectomy in anticoagulated patients with acute distal and medium vessel stroke
Salim, Hamza , Musmar, Basel , Adeeb, Nimer , Yedavalli, Vivek , Lakhani, Dhairya A. , Grewal, Sahibjot , Henninger, Nils , Sundararajan, Sri Hari , Khalife, Jane , Tan, Benjamin Yong‐Qiang , Regenhardt, Robert W. , Heit, Jeremy J. , Cancelliere, Nicole M , Rouchaud, Aymeric , Sheth, Sunil G. , Puri, Ajit S , Dyzmann, Christian , Colasurdo, Marco , Barreau, Xavier , Filipe, João Pedro , Abdalkader, Mohamad , Marotta, Thomas R. , Spears, Julian , Biswas, Arundhati , Clarençon, Frédéric , Varela, Ricardo , Baker, Amanda , Essibayi, Muhammed Amir , Altschul, David , Gonzalez, Nestor R. , Möhlenbruch, Markus , Costalat, Vincent , Gory, Benjamin , Stracke, Christian Paul , Shaikh, Hamza , Liebeskind, David S. , Alexandre, Andrea , Tancredi, Illario , Faizy, Tobias D. , Kalsoum, Erwah , Lubicz, Boris , Patel, Aman B. , Guenego, Adrien , Investigators, for the MAD MT, Valente, Iacopo , Hsieh, Cheng‐Yang , Lakhani, Dhairya , Scarcia, Luca , Regenhardt, Robert W , Fiehler, Jens , Alexandru Radu, Răzvan , Klein, Piers , Ota, Takahiro , Jabbour, Pascal , Nguyen, Thanh N , Essibayi, Muhammed Amir , Gonzalez, Nestor R , Möhlenbruch, Markus A , Liebeskind, David S. , Heit, Jeremy J , Altschul, David J , Musmar, Basel , Salim, Hamza , Yedavalli, Vivek S , Cancelliere, Nicole M , Rouchaud, Aymeric , Colasurdo, Marco , Henninger, Nils , Tan, Benjamin Yq , Alexandre, Andrea M , Varela, Ricardo , Naamani, Kareem El , Kühn, Anna Luisa , Ghozy, Sherief , Bernstock, Joshua D. , Fiehler, Jens , Sheth, Sunil, Renieri, Leonardo , Harker, Pablo , Radu, Răzvan Alexandru , Klein, Piers , Mowla, Ashkan , Jabbour, Pascal , Siegler, James E. , Nguyen, Thanh N. , Baker, Amanda, Aziz‐Sultan, Mohammad Ali , Hecker, Constantin , Pedicelli, Alessandro , Mendes Pereira, Vitor , Dmytriw, Adam A.

European Stroke Journal | May 10, 2024 | Volume: 9 | Issue: 4 | Pages: 896-906

10.1177/23969873241249295 | PMID 38726983 Get It

Abstract Background: Stroke remains a major health concern globally, with oral anticoagulants widely prescribed for stroke prevention. The efficacy and safety of mechanical thrombectomy (MT) in anticoagulated patients with distal medium vessel occlusions (DMVO) are not well understood. Methods: This retrospective analysis involved 1282 acute ischemic stroke (AIS) patients who underwent MT in 37 centers across North America, Asia, and Europe from September 2017 to July 2023. Data on demographics, clinical presentation, treatment specifics, and outcomes were collected. The primary outcomes were functional outcomes at 90 days post-MT, measured by modified Rankin Scale (mRS) scores. Secondary outcomes included reperfusion rates, mortality, and hemorrhagic complications. Results: Of the patients, 223 (34%) were on anticoagulation therapy. Anticoagulated patients were older (median age 78 vs 74 years; p &lt; 0.001) and had a higher prevalence of atrial fibrillation (77% vs 26%; p &lt; 0.001). Their baseline National Institutes of Health Stroke Scale (NIHSS) scores were also higher (median 12 vs 9; p = 0.002). Before propensity score matching (PSM), anticoagulated patients had similar rates of favorable 90-day outcomes (mRS 0–1: 30% vs 37%, p = 0.1; mRS 0–2: 47% vs 50%, p = 0.41) but higher mortality (26% vs 17%, p = 0.008). After PSM, there were no significant differences in outcomes between the two groups. Conclusion: Anticoagulated patients undergoing MT for AIS due to DMVO did not show significant differences in 90-day mRS outcomes, reperfusion, or hemorrhage compared to non-anticoagulated patients after adjustment for covariates.
The impact of sugammadex dosing and administration practices on potential cost savings for pharmacy departments
Linn, Dustin D , Renew, J. Ross , Renew, Johnathan R

American Journal of Health-System Pharmacy | May 10, 2024 | Volume: 81 | Issue: 19 | Pages: e575-e583

10.1093/ajhp/zxae124 | PMID 38725325 Get It

Abstract Purpose Neuromuscular blocking agents (NMBAs) are commonly used during surgery, and restoring neuromuscular function at the end of surgery is vital in preventing complications of residual paralysis. Recent guidelines from the American Society of Anesthesiology recommend using sugammadex over neostigmine; however, sugammadex is significantly more expensive than neostigmine and may increase drug expenditure for pharmacy departments. This review summarizes evidence evaluating sugammadex dose adjustments and the potential of these dose adjustments to lead to cost savings for pharmacy departments. Summary We found evidence suggesting that the manufacturer-recommended sugammadex dose may not be needed in many patients and that dosing based on an adjusted body weight or based on depth of neuromuscular blockade may lead to lower sugammadex usage. Combining sugammadex with neostigmine could also decrease the dose of sugammadex required. We have highlighted the importance of objective neuromuscular monitoring to guide sugammadex dosing and evaluation for residual neuromuscular blockade. Cost savings for pharmacy departments may be realized by these alternative dosing strategies and/or vial-splitting practices. Conclusion Implementing practices related to sugammadex vial splitting and dose adjustment based on body weight and depth of neuromuscular blockade shows potential benefits in terms of sugammadex cost savings.